Alcon AG
ALC96.400USD
-1.209-1.24%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
47.68BCap. mercado
46.84P/E TTM
Más Datos de Alcon AG Compañía
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Información de la empresa
Código de la empresaALC
Nombre de la empresaAlcon AG
Fecha de salida a bolsaApr 09, 2019
Fundada en2018
Director ejecutivoMr. David J. Endicott
Número de empleados25599
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 09
DirecciónRue Louis d'Affry 6
CiudadFRIBOURG
Bolsa de valoresSIX Swiss Exchange
PaísSwitzerland
Código postal1701
Teléfono41589112222
Sitio Webhttps://www.alcon.ch/
Código de la empresaALC
Fecha de salida a bolsaApr 09, 2019
Fundada en2018
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Mr. Leon Sergio Duplan Fraustro
Mr. Leon Sergio Duplan Fraustro
Senior Vice President, President - Americas
Senior Vice President, President - Americas
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
4.51B
45.86%
Other
4.13B
42.01%
China
560.00M
5.69%
Japan
554.00M
5.63%
Switzerland
79.00M
0.80%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
Accionista
Hora de actualización: jue., 13 de mar
Hora de actualización: jue., 13 de mar
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
UBS Asset Management (Switzerland)
5.84%
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.87%
T. Rowe Price Investment Management, Inc.
3.02%
Fidelity Management & Research Company LLC
3.01%
Other
79.32%
Estadísticas de accionistas
Accionista
Proporción
UBS Asset Management (Switzerland)
5.84%
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.87%
T. Rowe Price Investment Management, Inc.
3.02%
Fidelity Management & Research Company LLC
3.01%
Other
79.32%
Tipo
Accionista
Proporción
Investment Advisor
33.93%
Investment Advisor/Hedge Fund
29.79%
Bank and Trust
4.48%
Sovereign Wealth Fund
2.61%
Hedge Fund
2.45%
Pension Fund
1.44%
Research Firm
1.23%
Individual Investor
0.13%
Insurance Company
0.10%
Other
23.84%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1610
381.09M
76.26%
+43.43M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
2023Q1
1566
324.92M
65.02%
+2.70M
2022Q4
1564
305.91M
61.22%
-40.51M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
UBS Asset Management (Switzerland)
29.21M
5.84%
+29.21M
--
Dec 31, 2024
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
19.35M
3.87%
+211.11K
+1.10%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
15.08M
3.02%
+8.71M
+136.76%
Feb 03, 2025
Fidelity Management & Research Company LLC
12.09M
2.42%
+611.30K
+5.32%
Dec 31, 2024
Aristotle Capital Management, LLC
12.83M
2.57%
-82.71K
-0.64%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
12.62M
2.53%
+276.47K
+2.24%
Dec 31, 2024
UBS Fund Management (Switzerland) AG
11.93M
2.39%
+211.04K
+1.80%
Dec 31, 2024
Zürcher Kantonalbank (Asset Management)
8.93M
1.79%
+306.70K
+3.56%
Dec 31, 2024
Harding Loevner LP
8.48M
1.7%
-795.85K
-8.58%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Global X Aging Population ETF
3.13%
Franklin FTSE Switzerland ETF
2.92%
iShares MSCI Switzerland ETF
2.87%
First Trust Switzerland Alphadex Fund
2.55%
Running Oak Efficient Growth ETF
1.99%
BNY Mellon Women's Opportunities ETF
1.96%
Global X S&P Catholic Values Developed ex-US ETF
1.43%
First Trust Indxx Medical Devices ETF
1.28%
iShares Global Healthcare ETF
0.62%
Wahed Dow Jones Islamic World ETF
0.57%
Ver más
Global X Aging Population ETF
Proporción3.13%
Franklin FTSE Switzerland ETF
Proporción2.92%
iShares MSCI Switzerland ETF
Proporción2.87%
First Trust Switzerland Alphadex Fund
Proporción2.55%
Running Oak Efficient Growth ETF
Proporción1.99%
BNY Mellon Women's Opportunities ETF
Proporción1.96%
Global X S&P Catholic Values Developed ex-US ETF
Proporción1.43%
First Trust Indxx Medical Devices ETF
Proporción1.28%
iShares Global Healthcare ETF
Proporción0.62%
Wahed Dow Jones Islamic World ETF
Proporción0.57%
Dividendos
Un total de
400.00M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos